Log In
Print this Print this

ELAD system

  Manage Alerts
Collapse Summary General Information
Company Vital Therapies Inc.
DescriptionHuman liver cell-based extracorporeal liver assist device (ELAD)
Molecular Target
Mechanism of ActionNA
Therapeutic ModalityMedical Devices: Other device
Latest Stage of DevelopmentPhase III
Standard IndicationLiver failure
Indication DetailsStabilize liver function in patients with acute-on-chronic hepatitis; Treat acute liver failure; Treat alcohol-induced liver decompensation (AILD); Treat fulminant hepatic failure (FHF); Treat severe acute alcoholic hepatitis
Regulatory Designation U.S. - Orphan Drug (Treat acute liver failure);
EU - Orphan Drug (Treat acute liver failure)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today